The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...
The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...